Get the Stockscreener App
26.57
13.30%
3.12
Pre-market:
26.45
-0.12
-0.45%
Chewy Inc stock is traded at $26.57, with a volume of 23.60M.
It is up +13.30% in the last 24 hours and up +0.42% over the past month.
Chewy is the largest e-commerce petcare retailer in the US, generating $11.9 billion in fiscal 2024 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending time developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods like crates, leashes, and bowls.
See More
Previous Close:
$23.45
Open:
$25.955
24h Volume:
23.60M
Relative Volume:
2.97
Market Cap:
$11.03B
Revenue:
$12.58B
Net Income/Loss:
$206.39M
P/E Ratio:
54.87
EPS:
0.4842
Net Cash Flow:
$487.01M
1W Performance:
+9.21%
1M Performance:
+0.42%
6M Performance:
-29.99%
1Y Performance:
-20.95%
1-Day Range:
$25.00
$27.40
1-Week Range:
$22.74
$27.40
52-Week Range:
$22.74
$48.62
Chewy Inc Stock (CHWY) Company Profile
Name
Chewy Inc
Sector
Industry
Phone
786-320-7111
Address
7700 WEST SUNRISE BOULEVARD, PLANTATION, FL
Compare CHWY vs AMZN, BABA, PDD, MELI, SE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CHWY
Chewy Inc
|
26.57 | 11.03B | 12.58B | 206.39M | 487.01M | 0.4842 |
AMZN
Amazon Com Inc
|
211.71 | 2.27T | 716.92B | 77.67B | 7.70B | 7.1722 |
BABA
Alibaba Group Holding Ltd Adr
|
129.87 | 310.05B | 141.52B | 12.89B | 12.98B | 5.3795 |
PDD
Pdd Holdings Inc Adr
|
102.61 | 145.67B | 58.04B | 14.19B | 15.91B | 9.5651 |
MELI
Mercadolibre Inc
|
1,639.47 | 83.12B | 28.89B | 2.00B | 7.95B | 39.39 |
SE
Sea Ltd Adr
|
82.47 | 48.82B | 22.93B | 1.61B | 5.02B | 2.5785 |
Chewy Inc Stock (CHWY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-19-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-25-25 | Upgrade | MoffettNathanson | Neutral → Buy |
| Sep-11-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-11-25 | Upgrade | Seaport Research Partners | Neutral → Buy |
| Sep-08-25 | Upgrade | Mizuho | Neutral → Outperform |
| Jul-10-25 | Resumed | Citizens JMP | Mkt Outperform |
| Jun-09-25 | Downgrade | Mizuho | Outperform → Neutral |
| Jun-05-25 | Downgrade | Jefferies | Buy → Hold |
| Mar-24-25 | Initiated | Seaport Research Partners | Neutral |
| Jan-23-25 | Upgrade | Argus | Hold → Buy |
| Jan-13-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-06-25 | Upgrade | Mizuho | Neutral → Outperform |
| Jan-03-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-05-24 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Nov-20-24 | Upgrade | BofA Securities | Underperform → Buy |
| Nov-08-24 | Upgrade | Citigroup | Neutral → Buy |
| Oct-23-24 | Resumed | Needham | Hold |
| Oct-09-24 | Initiated | TD Cowen | Buy |
| Aug-23-24 | Resumed | Piper Sandler | Overweight |
| Aug-21-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-16-24 | Initiated | Wolfe Research | Peer Perform |
| Jul-09-24 | Downgrade | Argus | Buy → Hold |
| Mar-19-24 | Initiated | Mizuho | Neutral |
| Jan-11-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-10-24 | Resumed | Goldman | Buy |
| Dec-19-23 | Initiated | Jefferies | Buy |
| Oct-31-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-25-23 | Upgrade | UBS | Sell → Neutral |
| Oct-19-23 | Resumed | BofA Securities | Underperform |
| Sep-20-23 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-06-23 | Upgrade | Argus | Hold → Buy |
| Sep-01-23 | Reiterated | Guggenheim | Buy |
| Aug-31-23 | Reiterated | Barclays | Equal Weight |
| Aug-31-23 | Reiterated | Citigroup | Neutral |
| Aug-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Aug-31-23 | Reiterated | JP Morgan | Overweight |
| Aug-31-23 | Reiterated | Morgan Stanley | Equal-Weight |
| Aug-31-23 | Reiterated | Needham | Buy |
| Aug-31-23 | Reiterated | Oppenheimer | Outperform |
| Aug-31-23 | Reiterated | Piper Sandler | Neutral |
| Aug-31-23 | Reiterated | RBC Capital Mkts | Outperform |
| Aug-31-23 | Reiterated | Robert W. Baird | Outperform |
| Aug-31-23 | Reiterated | UBS | Sell |
| Aug-25-23 | Reiterated | Wedbush | Outperform |
| Jul-17-23 | Upgrade | Goldman | Neutral → Buy |
| Jun-01-23 | Upgrade | Gordon Haskett | Hold → Buy |
| May-03-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-19-23 | Initiated | Argus | Hold |
| Apr-11-23 | Initiated | JMP Securities | Mkt Outperform |
| Mar-23-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Mar-10-23 | Initiated | ROTH MKM | Buy |
| Feb-15-23 | Initiated | Gordon Haskett | Hold |
| Jan-27-23 | Upgrade | Wedbush | Neutral → Outperform |
| Dec-07-22 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Nov-15-22 | Initiated | MoffettNathanson | Market Perform |
| Oct-07-22 | Initiated | Oppenheimer | Outperform |
| Jul-26-22 | Downgrade | Wedbush | Outperform → Neutral |
| Jun-27-22 | Upgrade | Needham | Hold → Buy |
| Jun-21-22 | Upgrade | Wedbush | Neutral → Outperform |
| Mar-11-22 | Initiated | Deutsche Bank | Buy |
| Jan-28-22 | Initiated | RBC Capital Mkts | Outperform |
| Jan-07-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-16-21 | Reiterated | Citigroup | Neutral |
| Dec-13-21 | Reiterated | Piper Sandler | Overweight |
| Dec-10-21 | Reiterated | Barclays | Equal Weight |
| Dec-10-21 | Reiterated | JP Morgan | Overweight |
| Dec-10-21 | Reiterated | Jefferies | Buy |
| Dec-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Dec-10-21 | Reiterated | UBS | Sell |
| Dec-10-21 | Reiterated | Wells Fargo | Overweight |
| Dec-06-21 | Downgrade | Wedbush | Outperform → Neutral |
| Sep-28-21 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-27-21 | Resumed | Credit Suisse | Outperform |
| Sep-13-21 | Initiated | Goldman | Neutral |
| Sep-02-21 | Reiterated | Barclays | Equal Weight |
| Sep-02-21 | Reiterated | Jefferies | Buy |
| Sep-02-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-28-21 | Initiated | Robert W. Baird | Outperform |
| Jul-16-21 | Initiated | Exane BNP Paribas | Outperform |
| Jul-08-21 | Initiated | Needham | Hold |
| May-03-21 | Initiated | Guggenheim | Buy |
| Apr-06-21 | Resumed | Evercore ISI | Outperform |
| Apr-01-21 | Initiated | Wolfe Research | Peer Perform |
| Mar-09-21 | Initiated | Citigroup | Neutral |
| Jan-19-21 | Downgrade | UBS | Neutral → Sell |
| Jan-13-21 | Reiterated | Credit Suisse | Outperform |
| Dec-17-20 | Reiterated | Needham | Buy |
| Nov-13-20 | Initiated | Piper Sandler | Overweight |
| Oct-16-20 | Upgrade | Jefferies | Hold → Buy |
| Sep-11-20 | Reiterated | Barclays | Equal Weight |
| Sep-11-20 | Reiterated | Credit Suisse | Outperform |
| Sep-11-20 | Reiterated | Jefferies | Hold |
| Sep-11-20 | Reiterated | Morgan Stanley | Equal-Weight |
| Sep-11-20 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-08-20 | Reiterated | Barclays | Equal Weight |
| Aug-28-20 | Reiterated | Wells Fargo | Overweight |
| Jul-15-20 | Initiated | Cleveland Research | Buy |
| Jun-22-20 | Reiterated | Morgan Stanley | Equal-Weight |
| Jun-10-20 | Reiterated | Barclays | Equal Weight |
| Jun-10-20 | Reiterated | BofA/Merrill | Buy |
| Jun-10-20 | Reiterated | Credit Suisse | Outperform |
| Jun-10-20 | Reiterated | JP Morgan | Overweight |
| Jun-10-20 | Reiterated | Nomura | Buy |
| Jun-10-20 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-10-20 | Reiterated | UBS | Neutral |
| Jun-10-20 | Reiterated | Wedbush | Outperform |
View All
Chewy Inc Stock (CHWY) Latest News
Dow surges over 300 points; Chewy shares jump on upbeat earnings - MSN
After nailing subscription, Chewy eyes AI and new categories - Modern Retail
Chewy Inc (CHWY): A Strategic SWOT Insight - GuruFocus
Chewy’s 'Easy to Install' Cat Climbing Wall Shelves Are 52% Off, and Shoppers Say They Last for Years - Parade
Chewy Just Popped. Is the Pet Stock a Buy Now? - AOL.com
Chewy (CHWY) Margin Compression Challenges Premium P/E Narrative After Q3 FY 2026 Results - simplywall.st
Chewy Inc (CHWY) climbs 13.3% on upbeat sales outlook - MSN
Chewy Inc (CHWY) Climbs 13.3% on Upbeat Sales Outlook - Insider Monkey
10 Stocks Investors Are Buying Now: Chewy, Braze, Sarepta, and More - Insider Monkey
Why Chewy Stock Rallied Today - The Motley Fool
Chewy, Inc. 2026 Q4ResultsEarnings Call Presentation (NYSE:CHWY) 2026-03-25 - Seeking Alpha
Why Chewy Stock Rallied Today - The Motley Fool
BNP Paribas Exane cuts Chewy stock price target on margin concerns - Investing.com
Chewy CEO: Consumers are 'highly engaged' even as inflation squeezes budgets - Yahoo Finance
Goldman Sachs cuts Chewy stock price target to $46 on Q4 results - Investing.com
Chewy Inc (CHWY) Q4 2025 Earnings Call Highlights: Strong Sales Growth and Strategic AI Investments By GuruFocus - Investing.com Canada
Chewy to Deliver Consistent Margin Expansion, Long-Term Adjusted EBITDA 10% Margin Target, Wedbush Says - marketscreener.com
Chewy: Expanding Margin Profile (NYSE:CHWY) - Seeking Alpha
Chewy Sees Unusually High Options Volume (NYSE:CHWY) - MarketBeat
Market movers: Sarepta Therapeutics, Chewy, Merck, Cognyte Software… - Proactive financial news
Chewy Inc (CHWY) Q4 2025 Earnings Call Highlights: Strong Sales Growth and Strategic AI Investments - GuruFocus
Chewy says pet ownership to keep increasing despite worries about rising costs - MarketWatch
Chewy CEO Flags Flat Pricing, Rising E-Commerce Shift And AI Push As Pet Care Industry Holds Course Into 2026 - Stocktwits
Stock Market Today (LIVE): On Holdings' Maguire Adds Operational Rigor; Chewy Delivers Growth on All Fronts - The Motley Fool
Chewy Forecasts Another Year of Sales Growth, Margin Expansion - WSJ
BofA cuts Chewy stock price target on valuation to $40 from $46 - Investing.com
Chewy Stock Surges On Strong Q4 Results And Guidance - Benzinga
Chewy CEO Sumit Singh on Q4 earnings: 'Nothing but bullish' on 2026 - MSN
Chewy Announces Fiscal Fourth Quarter and Full Year 2025 Financial Results - foodmarket.com
Mizuho reiterates Chewy stock Outperform rating at $50 target By Investing.com - Investing.com UK
Chewy shares jump after strong fourth-quarter earnings beat - MSN
Watch CNBC's full interview with Chewy CEO Sumit Singh - CNBC
Chewy (NYSE:CHWY) Shares Gap UpTime to Buy? - MarketBeat
Chewy (CHWY) Reports Strong Q4 Earnings and Revenue Growth - GuruFocus
Chewy's Record $232M Cash Flow Silences Critics: Shares Surge Despite Mixed Revenue Signals - The Chronicle-Journal
Chewy: This Is What A Mispriced Growth Stock Looks Like (Upgrade) (NYSE:CHWY) - Seeking Alpha
Why Chewy Stock Is Rallying Despite An Earnings Miss - Investor's Business Daily
Chewy jumps 15% as investors position for fiscal Q4 and full-year results - Quiver Quantitative
Why Chewy stock is rallying despite an earnings miss - MSN
Chewy (CHWY) Shares Surge 15% Amidst Market Activity - GuruFocus
Barclays reiterates Chewy stock Overweight rating on revenue outlook - Investing.com
Chewy Inc stock faces renewed pressure amid pet care sector slowdown and e-commerce margin challenge - AD HOC NEWS
Chewy Q4 Earnings Call Highlights - MarketBeat
Chewy Gives Upbeat 2026 Sales Outlook Following Fourth-Quarter Miss - marketscreener.com
Chewy Q4 2025 slides: autoship drives 8% growth, stock surges 11% - Investing.com
Chewy (CHWY) Projects Optimistic 2026 Outlook - GuruFocus
Chewy issues upbeat outlook as profit, revenue rise - MSN
Chewy shares jump on strong results, upbeat outlook - Yahoo! Finance Canada
Chewy (NYSE:CHWY) Announces Earnings Results - MarketBeat
Jefferies reiterates Chewy stock rating citing customer growth - Investing.com
Earnings call transcript: Chewy Inc. Q4 2025 beats EPS expectations, stock rises - Investing.com
Chewy Inc Stock (CHWY) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.77%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):